Home  |  Archive  |  AJA @ Nature  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

 

- Advance Online Publication
- Current Issue
- Free Sample Issue
- Browse by Volume
- Browse by Category
- Acknowledgments
- Special Issues
- AJA @ NPG

- Online Submission
- Online Review
- Instruction for Authors
- Instruction for Reviewers
- English Corner

- About AJA
- Editorial Board
- Contact Us
- News

- Nature.com
- Nature Publishing Group

- Advertisement
- Subscription
- Email alert
- Proceedings
- Reprints

- Copyright Licence
- Subscription
- Free Sample

- Journals
- Societies & Institutes
- Hospitals
- Databases & Libraries
- Companies
- Websites
- Meetings
- Other links

Abstract

《亚洲男性学杂志》 2012; 14 (3): 405–408

Cyr61,一个潜在的前列腺癌预后生物标记物

Naoki Terada, Prakash Kulkarni and Robert H Getzenberg (美国)

富半胱氨酸血管生成诱导因子61(Cyr61)是一种细胞外基质蛋白,与生长因子和激素的信号转导相关,且其表达量在几种癌症中会经常发生变化。Cyr61在器官局限性前列腺癌中呈高度表达。此外,Cyr61的表达水平与较低的疾病复发风险相关,且在血清中能够定量测定。综合考虑,上述结果表明Cyr61是一种潜在的,临床上实用的、基于组织和血清的生物标记物,可用于区分致死及非致死性前列腺癌。

关键词:Cyr61,致死性前列腺癌,非致死性前列腺癌,过度诊断,过度治疗,前列腺癌

此摘要文献来源:
Naoki Terada, Prakash Kulkarni and Robert H Getzenberg. Cyr61 is a potential prognostic marker for prostate cancer. Asian J Androl 2012; 14: 405–408.

Copyright 1999-2013    Shanghai Materia Medica, Shanghai Jiao Tong University.    All rights reserved